Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery (RCT-ESPB)
Spondylolisthesis, Lumbar Disc Herniation, Lumbar Spinal Stenosis
About this trial
This is an interventional treatment trial for Spondylolisthesis focused on measuring Erector spinae block, Lumbar interbody fusion, Regional anesthesia, Postoperative pain
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years;
- Patients planned for elective lumbar spinal fusion surgery with a dorsal surgical approach;
- 2-4 level spine fusion surgery;
- Written informed consent.
Exclusion Criteria:
- A Body Mass Index (BMI) > 40 kg/m²;
- ASA physical health classification > 3;
- Patients who will undergo spine surgery involving less than 2 or more than 4 levels of fusion, scoliosis surgery*;
- Patients who will undergo circumferent spine surgery;
- Patients with an active, local infection or systemic infection;
- Patients with an allergy to one or more medications used in the study;
- Patients with any contraindication to a regional anesthetic technique;
- Kidney- or liver failure inhibiting the systemic use of paracetamol and/or NSAIDs;
- Acute surgeries;
- Patients with a history of drugs or alcohol abuse;
- Pregnancy;
- Cognitive impairment;
- Inability to speak or understand the Dutch language.
Sites / Locations
- Sint MaartenskliniekRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
ESPB with ropivacaine
ESPB with placebo
Patients in the experimental group will receive locoregional analgesia via ESPB with injectate consisting of ropivacaine 0.375 mg/mL with no additives, two times 30mL bilaterally at the transverse processs of the T12-vertebra (total dose of 225 mg).
Patients in the placebo group will receive an injection performed as the procedure of ESPB with injectate consisting of sodiumchloride 0.9% with no additives, two times 30mL bilaterally at the transverse processs of the T12-vertebra.